ARCHIVES

New FDA Commisioner’s Top Priorities: FDAMA Implimitation, Agency’s Science

This article is from The Cancer Letter archive.

Vol. 25 No. 01 | January 8, 1999

Download PDF Visit The Full Archive

Related Articles

Breast Cancer Family History Doesn’t Increase Risk Of Ovarian Cancer, Study Says

September 30, 2005

Center Directors Solidly opposed To Core grant changes, Ask Upton, NCAB To Find Other Solutions

November 11, 1977

Rosenberg’s Gene Transfer Protocol Approved By NIH Advisory Group

October 7, 1988

RFA Announced On Model For Planning community Prevention Program

October 20, 1978

Variation in Breast Density May Be Strong Risk Factor

July 27, 2012

Centers Program Needs ‘Innovative Additions’ Such as SPORE Grants

September 20, 1991